FDA Inspection
Sun Pharmaceutical Medicare LimitedSun Pharmaceutical Medicare Limited – FDA Inspection, Feb 5, 2019
Record Details
This FDA Inspection record concerns Sun Pharmaceutical Medicare Limited, with an inspection on February 5, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f16ce15f-424a-4596-92fe-b45d39588c66
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1078834
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sun Pharmaceutical Medicare Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | Not classified | Office of Inspections and Investigations | |
| February 27, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | Not classified | Office of Inspections and Investigations | |
| August 11, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Sun Pharmaceutical Medicare Limited
- FDA Inspection 1288660 - 2025-09-19
- FDA Inspection 1231121 - 2024-02-27
- FDA Inspection 1210949 - 2023-07-13
- FDA Inspection 1037571 - 2017-11-17
- FDA Inspection 1025918 - 2017-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.